Regarding treatment of dysbiosis, what are the implications of the bold part below?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300896/
Interestingly, several studies have indicated that the outer membrane compounds of A. muciniphila, or pasteurized bacteria, have greater therapeutic potential for metabolic, inflammatory, and autoimmune diseases than live A. muciniphila (36–38). Notably, Kang et al. (2013) reported a change in the composition of EVs in the feces of mice with DSS-induced UC, such as a decrease in the EVs of
A. muciniphila and
Bacteroides acidifaciens. In the same study, OMVs from
A. muciniphila (AmOMV) suppressed the production of IL-6 in colonic epithelial cells (CT26 cell line) stimulated with OMVs from
Escherichia coli in vitro, and oral administration of AmOMV, but not viable bacteria, attenuated DSS-induced colitis
in vivo (
36). Additionally, in a murine model of high-fat diet (HFD)–induced intestinal dysbiosis, AmOMVs improved the intestinal mucosal barrier function, increased the expression of TJs and IL-10, and inhibited inflammatory markers in the colon. AmOMVs are also able to reduce intestinal permeability, increase the expression of TJs
via AMP-activated protein kinase (AMPK), inhibit TLR-4 and interferon-alpha (IFN-α) expression, and increase TLR-2 expression and IL-4 production in Caco-2 cell lines
in vitro (
39,
40). These data indicate that
A. muciniphila components and their OMVs may be potential therapeutic targets for IBD.
How often do people use this type of probiotic? I hadn't heard of it.
https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2023.1304232/full
In this study, we used B. acidifaciens to interfere with dextran sulfate sodium (DSS)-induced colitis in mice, revealing its anti-inflammatory and barrier protection effects on enteritis mice. The effects of B. acidifaciens-mediated microorganisms and their metabolites on alleviating the symptoms of enteritis mice were confirmed by fecal bacteria transplantation (FMT) and aseptic fecal filtrate transplantation (FFT). Finally, we found that EVs of B. acidifaciens can inhibit inflammatory reactions, repair the intestinal mucosal barrier, and finally alleviate colitis in mice. Through proteomic analysis, it was confirmed that the functional proteins of B. acidifaciens and B. acidifaciens-EVs were different.
I think that someone already linked to the below paper previously. But is the idea that you must continuously take probiotic pills because otherwise the effect will be temporary?
https://www.cell.com/cell/fulltext/S0092-8674(18)31102-4
Empiric probiotics are commonly consumed by healthy individuals as means of life quality improvement and disease prevention. However, evidence of probiotic gut mucosal colonization efficacy remains sparse and controversial. We metagenomically characterized the murine and human mucosal-associated gastrointestinal microbiome and found it to only partially correlate with stool microbiome. A sequential invasive multi-omics measurement at baseline and during consumption of an 11-strain probiotic combination or placebo demonstrated that probiotics remain viable upon gastrointestinal passage. In colonized, but not germ-free mice, probiotics encountered a marked mucosal colonization resistance. In contrast, humans featured person-, region- and strain-specific mucosal colonization patterns, hallmarked by predictive baseline host and microbiome features, but indistinguishable by probiotics presence in stool. Consequently, probiotics induced a transient, individualized impact on mucosal community structure and gut transcriptome. Collectively, empiric probiotics supplementation may be limited in universally and persistently impacting the gut mucosa, meriting development of new personalized probiotic approaches.
What are the "new personalized probiotic approaches" exactly?
https://www.cell.com/cell/fulltext/S0092-8674(18)31102-4
empiric probiotics supplementation may be limited in universally and persistently impacting the gut mucosa, meriting development of new personalized probiotic approaches.
I was just reading about probiotics. Just a couple questions. I know I just posted a few things; my apologies for posting so much. You can glue all my posts together if that's desirable.
1: I read this (
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300896/): "Interestingly, several studies have indicated that the outer membrane compounds of
A. muciniphila, or pasteurized bacteria, have greater therapeutic potential for metabolic, inflammatory, and autoimmune diseases than live
A. muciniphila (
36–
38)." Am I understanding correctly that the pasteurization process means that you will be ingesting (when you ingest the pasteurized product) the "outer membrane compounds" of the bacterium? And when will it be possible to get such products, assuming that the difference is actually significant?
2: A long time ago I saw a scientific article that went into detail about the microbiota-composition abnormalities associated with all of the various psychiatric conditions. One might imagine that you could look at that paper, find the bacteria that seem to be low in patients who have the same diagnoses that you do, and then supplement those bacteria. Do you guys know of any papers like that? I read this paper ages ago, it seems. There are probably some really good reviews looking at the various psychiatric diseases and the associated abnormalities.
3: I can understand the appeal of FMT. It seems much more intelligent to just transplant a healthy person's microbiome than to try to tinker with your own, right?
4: What is the best review that tackles the issue of what the "keystone" species of bacteria might be regarding human dysbiosis? I'm asking because it makes sense to try to find out what the "keystone" species are as opposed to tinkering with all sorts of non-"keystone" species.
5: What is the best review that goes through all of the non-standard probiotics that one might try? The below paragraph names some non-standard probiotics, but I wonder if there's a review that comprehensively lists the non-standard ones. See here:
There are a FEW other bacteria represented--like various Bacillus species, a few Clostridia (found in Pendulum brand probiotics only), Akkermansia muciniphila (again Pendulum only) a few strains of E. coli (Nissle, Symbioflor) you need to order from Europe to get, most recently a strain of Propionibacterium (the bacteria that make holes in Swiss cheese) and the soil-based bacteria Michael mentioned (the Bacillus species are soil bacteria too--however there are many OTHER soil-dwelling organisms found in a true "soil based" probiotic like Prescript-Assist). And there are yeast, you mention Saccharomyces boulardii, which is really just a special strain of ordinary baker's/brewer's yeast, S. cervisiae. While somewhat more diverse, again there's the caveat that (with the possible exception of Akkermansia), there's no reason to believe that these are major keystone species lost from the gut when you take antibiotics and whose absence is the cause of the "missing microbes" phenomenon.
1: What does everyone think of the products discussed here (
https://www.healthline.com/nutrition/seed-probiotics-review )?
2: The review that I just linked mentions various bacteria that I hadn't ever heard of. Are all of the ones below worth trying? And which of the ones listed below are actually unusual or "exotic"?
Bifidobacterium longum SD-BB536-JP, Bifidobacterium breve SD-BR3-IT, Lactiplantibacillus plantarum SD-LP1-IT, Lacticaseibacillus rhamnosus SD-LR6-IT, Lacticaseibacillus rhamnosus HRVD113-US, Bifidobacterium infantis SD-M63-JP, Bifidobacterium lactis SD-BS5-IT, Bifidobacterium lactis HRVD524-US, Lactobacillus crispatus SD-LCR01-IT, Lacticaseibacillus casei HRVD300-US, Bifidobacterium breve HRVD521-US, Bifidobacterium longum HRVD90b-US, Bifidobacterium lactis SD150-BE, Limosilactobacillus fermentum SD-LF8-IT, Lacticaseibacillus rhamnosus SD-GG-BE, Limosilactobacillus reuteri RD830-FR
Ligilactobacillus salivarius SD-LS1-IT, Bifidobacterium lactis SD-CECT8145-SP, Bifidobacterium longum SD-CECT7347-SP, Lacticaseibacillus casei SD-CECT9104-SP
Lactiplantibacillus plantarum SD-LPLDL-UK, Bifidobacterium lactis SD-MB2409-IT
Bifidobacterium adolescentis SD-BA5-IT, Limosilactobacillus reuteri SD-LRE2-IT
A few more things. Sorry to stack so many things up.
1: I found this paper to be very impressive and interesting:
https://www.sciencedirect.com/science/article/pii/S0278584623001471. Do you guys also find it to be an excellent paper?
2: Are any useful probiotics mentioned in the paper that aren’t yet available for consumers to purchase?
3: Is the type of probiotic talked about in this (
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787120/ ) paper worth trying?
4: Why would it make sense to supplement
Akkermansia instead of just supplementing other bacteria whose presence will then lead to an increase in one's levels of
Akkermansia?
5: What do you guys think of this video that talks about
Akkermansia?
https://www.youtube.com/watch?v=c656V9omekw
6: There's no way to know which one will be more effective for you if a given probiotic product comes in two different "strengths", right? It looks like this (
https://nowfoods.ca/product/probiotic-10-25-billion/ ) product comes in a 25 billion, a 50 billion, and a 100 billion "strength". It's just a matter of trial and error if you want to find out which one works best, since there are unpredictable dynamics that might make one "strength" too "weak" and another "strength" too "strong", correct?
7: Not sure if it's known for certain that there is indeed a parabola for every single probiotic product when it comes to "strength", but if there is in fact a parabola for a given product then it's unpredictable where the optimum of the parabola (past which the product is less effective because it's too "strong") is, correct?
8: What do you guys think about the importance of trying a "rainbow strategy" where you take 5 different probiotic products all at once? Is there a possible "synergy" that might be unlocked when you take a "rainbow" of 5 different pills at once? The "rainbow" strategy seems like it might work.
9: Is this (
https://aor.ca/product/postbiotic-boost/ ) product worth trying, do you think?
Is it possible to purchase any of the below-mentioned probiotics?
https://www.intechopen.com/chapters/88819
Autism spectrum disorder (ASD) is a disorder characterized by social and behavioral impairment. In addition to neurological symptoms, the patient often suffers from gastrointestinal abnormalities. Some microbial species have been linked to the pathogenesis of this disease; symptoms have been linked to a reduction of
Pretovella, Coprococcus, Veillonellaceae, and
Bracteroides fragilis and a reduction in the availability of TPH [
6,
14].
And how many of the probiotics mentioned in this (
https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2022.1103836/full ) review, including the ones in this (
https://www.frontiersin.org/files/Articles/1103836/fmicb-13-1103836-HTML/image_m/fmicb-13-1103836-t001.jpg ) table, can be purchased?
I wonder how many of these (
https://www.frontiersin.org/files/Articles/1103836/fmicb-13-1103836-HTML/image_m/fmicb-13-1103836-t003.jpg ) strains are purchasable. And I also wonder about the ones mentioned below:
https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2022.1103836/full
Butyrate-producing gut microbes are of significant therapeutic importance and are believed to be niche-specific next-generation probiotics. Multiple butyrate-producing probiotic strains of
Clostridium butyricum (
Stoeva et al., 2021) and
Butyricicoccus pullicaecorum (
Geirnaert et al., 2014;
Boesmans et al., 2018) have been used as they exhibit good bile tolerance, viability, and metabolic activity (
Table 3). Microbes of interest or butyrate producers can also be genetically manipulated to increase their butyrate-producing capacity. For example, heterologous genes required for butyrate production from acetyl-CoA can be introduced by inactivating the gene encoding the conversion of acetyl-CoA to acetate and the gene encoding the aldehyde/alcohol dehydrogenase for ethanol production or simply disrupting a CoA transferase gene, which may be an alternative route for acetate production (
Ueki et al., 2014;
Suo et al., 2018). Additionally, a co-culture strategy, that is an interactive microbial population of more than two microbes, can also be implemented to achieve higher levels of butyrate and increased abundance of butyrate producers in the gut. Co-culture of
F. prausnitzii and
Bifidobacterium catenulatum with fructooligosaccharides as an energy source resulted in a higher viable cell count and butyrate production (
Kim et al., 2020). Moreover, butyrate producers of animal origin (ruminants), such as cellulose-degrading
Ruminococcus albus and R. flavefaciens (
Flint et al., 2008;
Chassard et al., 2012), can also be considered to study their impact on human hosts.
Regarding this (
https://aor.ca/product/probiotic-3/ ) product, why is the ratio so skewed? One of the strains is present to a far higher degree than the other two; one strain is more than 18 times (!!!) more abundant in the product than the other two, which is striking to me.
Lastly, two things about this (
https://pendulumlife.com/blogs/news/what-is-clostridium-butyricum ) product.
1: Pendulum doesn't seem to sell it anymore. I contacted them asking if they no longer sell it and why they stopped selling it.
2: What do you guys make of the fact that this product "contains 15 million AFU of Clostridium butyricum, a powerful bacillus strain naturally found in the human gut"? I read that on another website, not Pendulum's. If it contains 15 million AFU then that's more than 15 times as much as the AOR product (
https://aor.ca/product/probiotic-3/ ) that only contains 0.6 million AFU of that same type of bacteria. It's such a huge difference; I wonder what you guys make of that.